WHO to start Ebola treatment trials

The World Health Organization has announced the initiation of a clinical trial in the Democratic Republic of the Congo to test the efficacy of two potential treatments for Ebola, MBP134 and Remdesivir, with the aim of reducing the mortality rate amidst ongoing outbreaks of the Bundibugyo strain. This initiative comes at a time when the country has recorded 1,094 cases and 277 deaths, with response efforts facing challenges related to funding shortages and security incidents. Additionally, the first confirmed case of Ebola has been reported in France, involving a doctor who was infected while working in Congo.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article